{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:59:21Z","timestamp":1791388761379,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00464-024-11084-3","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T16:19:05Z","timestamp":1724429945000},"page":"6846-6853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The predicting value of post neoadjuvant treatment magnetic resonance imaging: a meta-analysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7631-4757","authenticated-orcid":false,"given":"Yaniv","family":"Zager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Horesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Abdelmasseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Aquina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bustamante Lopez Leonardo","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark K.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R. T.","family":"Monson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"11084_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41575-020-0275-y","volume":"17","author":"DS Keller","year":"2020","unstructured":"Keller DS, Berho M, Perez RO, Wexner SD, Chand M (2020) The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol 17:414\u2013429","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11084_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","volume":"341","author":"JK MacFarlane","year":"1993","unstructured":"MacFarlane JK, Ryall RDH, Heald RJ (1993) Mesorectal excision for rectal cancer. The Lancet 341:457\u2013460","journal-title":"The Lancet"},{"key":"11084_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jama.284.8.1008","volume":"284","author":"C Camm\u00e0","year":"2000","unstructured":"Camm\u00e0 C et al (2000) Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284:1008","journal-title":"JAMA"},{"key":"11084_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","volume":"271","author":"F Petrelli","year":"2020","unstructured":"Petrelli F et al (2020) Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg 271:440\u2013448","journal-title":"Ann Surg"},{"key":"11084_CR5","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.3748\/wjg.v26.i29.4218","volume":"26","author":"F L\u00f3pez-Campos","year":"2020","unstructured":"L\u00f3pez-Campos F et al (2020) Watch and wait approach in rectal cancer: current controversies and future directions. World J Gastroenterol 26:4218\u20134239","journal-title":"World J Gastroenterol"},{"key":"11084_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/0284186X.2014.952387","volume":"54","author":"F Br\u00e4nnstr\u00f6m","year":"2015","unstructured":"Br\u00e4nnstr\u00f6m F et al (2015) Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncol 54:447\u2013453","journal-title":"Acta Oncol"},{"key":"11084_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/XCS.0000000000001064","author":"CM Harbaugh","year":"2024","unstructured":"Harbaugh CM et al (2024) Association of national accreditation program for rectal cancer accreditation with outcomes after rectal cancer surgery. J Am Coll Surg. https:\/\/doi.org\/10.1097\/XCS.0000000000001064","journal-title":"J Am Coll Surg"},{"key":"11084_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamaoncol.2021.1683","volume":"7","author":"OE Rahma","year":"2021","unstructured":"Rahma OE et al (2021) Use of total neoadjuvant therapy for locally advanced rectal cancer: initial results from the pembrolizumab arm of a phase 2 randomized clinical trial. JAMA Oncol 7:1225","journal-title":"JAMA Oncol"},{"key":"11084_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101739","volume":"43","author":"MC Fernandes","year":"2022","unstructured":"Fernandes MC, Gollub MJ, Brown G (2022) The importance of MRI for rectal cancer evaluation. Surg Oncol 43:101739","journal-title":"Surg Oncol"},{"key":"11084_CR10","doi-asserted-by":"publisher","first-page":"1031581","DOI":"10.3389\/fonc.2023.1031581","volume":"13","author":"PF Gao","year":"2023","unstructured":"Gao PF, Lu N, Liu WMRIVS (2023) FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer. Front Oncol 13:1031581","journal-title":"Front Oncol"},{"key":"11084_CR11","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.2214\/AJR.11.8210","volume":"199","author":"UB Patel","year":"2012","unstructured":"Patel UB et al (2012) MRI after treatment of locally advanced rectal cancer: how to report tumor response\u2014the mercury experience. Am J Roentgenol 199:W486\u2013W495","journal-title":"Am J Roentgenol"},{"key":"11084_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00259-022-05936-0","volume":"50","author":"A Herold","year":"2022","unstructured":"Herold A et al (2022) Added value of quantitative, multiparametric 18F-FDG PET\/MRI in the locoregional staging of rectal cancer. Eur J Nucl Med Mol Imaging 50:205\u2013217","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11084_CR13","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/codi.16641","volume":"25","author":"R Gefen","year":"2023","unstructured":"Gefen R et al (2023) How reliable is restaging MRI after neoadjuvant therapy in rectal cancer? Colorectal Dis 25:1631\u20131637","journal-title":"Colorectal Dis"},{"key":"11084_CR14","first-page":"258","volume":"96","author":"A-R Popi\u021ba","year":"2022","unstructured":"Popi\u021ba A-R et al (2022) Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer. Med Pharm Rep 96:258\u2013268","journal-title":"Med Pharm Rep"},{"key":"11084_CR15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19037","author":"M Aryan","year":"2021","unstructured":"Aryan M et al (2021) Utility of restaging MRI following neoadjuvant chemoradiotherapy for stage II-III rectal adenocarcinoma. Cureus. https:\/\/doi.org\/10.7759\/cureus.19037","journal-title":"Cureus"},{"key":"11084_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1148\/radiol.212905","volume":"305","author":"Q-Y Lu","year":"2022","unstructured":"Lu Q-Y et al (2022) Contrast-enhanced MRI for T restaging of locally advanced rectal cancer following neoadjuvant chemotherapy and radiation therapy. Radiology 305:364\u2013372","journal-title":"Radiology"},{"key":"11084_CR17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/DCR.0000000000002450","volume":"66","author":"S Deidda","year":"2023","unstructured":"Deidda S et al (2023) Limits of clinical restaging in detecting responders after neoadjuvant therapies for rectal cancer. Dis Colon Rectum 66:957\u2013964","journal-title":"Dis Colon Rectum"},{"key":"11084_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s10350-004-0851-1","volume":"48","author":"C-C Chen","year":"2005","unstructured":"Chen C-C, Lee R-C, Lin J-K, Wang L-W, Yang S-H (2005) How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 48:722\u2013728","journal-title":"Dis Colon Rectum"},{"key":"11084_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.rpor.2017.02.004","volume":"22","author":"R Vojt\u00ed\u0161ek","year":"2017","unstructured":"Vojt\u00ed\u0161ek R, Kor\u010d\u00e1kov\u00e1 E, Ma\u0159an J, \u0160orejs O, F\u00ednek J (2017) Neoadjuvant chemoradiotherapy of the rectal carcinoma\u2014the correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings. Rep Pract Oncol Radiother 22:265\u2013276","journal-title":"Rep Pract Oncol Radiother"},{"key":"11084_CR20","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1007\/s00261-019-01894-8","volume":"44","author":"SC Nahas","year":"2019","unstructured":"Nahas SC et al (2019) Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol 44:3632\u20133640","journal-title":"Abdom Radiol"},{"key":"11084_CR21","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.3748\/wjg.15.5563","volume":"15","author":"G Mezzi","year":"2009","unstructured":"Mezzi G et al (2009) Endoscopic ultrasound and magnetic resonance imaging forre-staging rectal cancer after radiotherapy. World J Gastroenterol 15:5563","journal-title":"World J Gastroenterol"},{"key":"11084_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4274\/dir.2022.221333","volume":"29","author":"H \u00c7elik","year":"2023","unstructured":"\u00c7elik H et al (2023) Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy. Diagn Interv Radiol 29:219\u2013227","journal-title":"Diagn Interv Radiol"},{"key":"11084_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.asjsur.2020.07.001","volume":"44","author":"S Laohawiriyakamol","year":"2021","unstructured":"Laohawiriyakamol S et al (2021) Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Asian J Surg 44:275\u2013279","journal-title":"Asian J Surg"},{"key":"11084_CR24","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s00261-018-1627-8","volume":"43","author":"M Aker","year":"2018","unstructured":"Aker M et al (2018) Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdom Radiol 43:3213\u20133219","journal-title":"Abdom Radiol"},{"key":"11084_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.surg.2010.03.025","volume":"149","author":"F Pomerri","year":"2011","unstructured":"Pomerri F et al (2011) Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery 149:56\u201364","journal-title":"Surgery"},{"key":"11084_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/DCR.0000000000000557","volume":"59","author":"DA Schneider","year":"2016","unstructured":"Schneider DA et al (2016) Relative value of restaging MRI, CT, and FDG-PET scan after preoperative chemoradiation for rectal cancer. Dis Colon Rectum 59:179\u2013186","journal-title":"Dis Colon Rectum"},{"key":"11084_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/jmri.28766","volume":"59","author":"Y Xia","year":"2024","unstructured":"Xia Y et al (2024) Computed diffusion-weighted images of rectal cancer: image quality, restaging, and treatment response after neoadjuvant therapy. J Magn Reson Imaging 59:297\u2013308","journal-title":"J Magn Reson Imaging"},{"key":"11084_CR28","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00268-009-0248-3","volume":"33","author":"YB Cho","year":"2009","unstructured":"Cho YB et al (2009) Accuracy of MRI and18 F-FDG PET\/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer. World J Surg 33:2688\u20132694","journal-title":"World J Surg"},{"key":"11084_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4143\/crt.2015.114","volume":"48","author":"B-H Kye","year":"2016","unstructured":"Kye B-H, Kim H-J, Kim G, Kim J-G, Cho H-M (2016) Multimodal assessments are needed for restaging after neoadjunvant chemoradiation therapy in rectal cancer patients. Cancer Res Treat 48:561\u2013566","journal-title":"Cancer Res Treat"},{"key":"11084_CR30","first-page":"168","volume":"89","author":"E Adrian Cot","year":"2018","unstructured":"Adrian Cot E et al (2018) The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy. Ann Ital Chir 89:168\u2013176","journal-title":"Ann Ital Chir"},{"key":"11084_CR31","first-page":"1","volume":"35","author":"CS Nahas","year":"2019","unstructured":"Nahas CS, Nahas SC, Bustamante-Lopez LE, Sparapan CM, Ortega CI, Azambuja R, Ribeiro Jr UL, Cotti GC, Imperiale AR, Cecconello IV (2019) T\u2264 2N0 TRG1-2 in post-chemoradiation therapy MRI: what can it predict? Surg Technol Int 35:161\u2013168","journal-title":"Surg Technol Int"},{"key":"11084_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40644-023-00589-0","volume":"23","author":"Z Zhang","year":"2023","unstructured":"Zhang Z et al (2023) MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison. Cancer Imaging 23:67","journal-title":"Cancer Imaging"},{"key":"11084_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00261-020-02708-y","volume":"46","author":"S Pangarkar","year":"2021","unstructured":"Pangarkar S et al (2021) Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases. Abdom Radiol 46:498\u2013505","journal-title":"Abdom Radiol"},{"key":"11084_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00432-014-1815-z","volume":"141","author":"JW Huh","year":"2015","unstructured":"Huh JW, Kwon SY, Lee JH, Kim HR (2015) Comparison of restaging accuracy of repeat FDG-PET\/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer. J Cancer Res Clin Oncol 141:353\u2013359","journal-title":"J Cancer Res Clin Oncol"},{"key":"11084_CR35","first-page":"62","volume":"20","author":"S Zhan","year":"2015","unstructured":"Zhan S, Wang X, Huang X, Zhu H (2015) Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy. JBUON 20:62\u201367","journal-title":"JBUON"},{"key":"11084_CR36","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.7150\/jca.32685","volume":"10","author":"L Yu","year":"2019","unstructured":"Yu L et al (2019) Accuracy of magnetic resonance imaging in staging rectal cancer with multidisciplinary team: a single-center experience. J Cancer 10:6594\u20136598","journal-title":"J Cancer"},{"key":"11084_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/DCR.0000000000002145","volume":"65","author":"JB Yuval","year":"2022","unstructured":"Yuval JB et al (2022) MRI at restaging after neoadjuvant therapy for rectal cancer overestimates circumferential resection margin proximity as determined by comparison with whole-mount pathology. Dis Colon Rectum 65:489\u2013496","journal-title":"Dis Colon Rectum"},{"key":"11084_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1148\/radiol.11102135","volume":"260","author":"MJ Park","year":"2011","unstructured":"Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H (2011) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 260:771\u2013780","journal-title":"Radiology"},{"key":"11084_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.106991","volume":"49","author":"SJD Temmink","year":"2023","unstructured":"Temmink SJD, Martling A, Angenete E, Nilsson PJ (2023) Complete response rates in rectal cancer: temporal changes over a decade in a population-based nationwide cohort. Eur J Surg Oncol 49:106991","journal-title":"Eur J Surg Oncol"},{"key":"11084_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2021-001716","volume":"11","author":"S Bregendahl","year":"2022","unstructured":"Bregendahl S et al (2022) Training of radiology specialists in local staging of primary rectal cancer on MRI: a prospective intervention study exploring the impact of various educational elements on the interpretive performance. BMJ Open Qual 11:e001716","journal-title":"BMJ Open Qual"},{"key":"11084_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.crad.2019.04.015","volume":"74","author":"PJ Brown","year":"2019","unstructured":"Brown PJ et al (2019) Radiologist and multidisciplinary team clinician opinions on the quality of MRI rectal cancer staging reports: how are we doing? Clin Radiol 74:637\u2013642","journal-title":"Clin Radiol"},{"key":"11084_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/RCT.0000000000000964","volume":"44","author":"M-Z Wei","year":"2020","unstructured":"Wei M-Z, Zhao Z-H, Wang J-Y (2020) The diagnostic accuracy of magnetic resonance imaging in restaging of rectal cancer after preoperative chemoradiotherapy: a meta-analysis and systematic review. J Comput Assist Tomogr 44:102\u2013110","journal-title":"J Comput Assist Tomogr"},{"key":"11084_CR43","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/codi.12976","volume":"17","author":"S Memon","year":"2015","unstructured":"Memon S, Lynch AC, Bressel M, Wise AG, Heriot AG (2015) Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. Colorectal Dis 17:748\u2013761","journal-title":"Colorectal Dis"},{"key":"11084_CR44","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2023.00142","author":"G Di Costanzo","year":"2023","unstructured":"Di Costanzo G et al (2023) Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer a review. Explor Target Anti-Tumor Ther. https:\/\/doi.org\/10.37349\/etat.2023.00142","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"11084_CR45","doi-asserted-by":"publisher","first-page":"e2110","DOI":"10.1002\/onco.13955","volume":"26","author":"J Trojan","year":"2021","unstructured":"Trojan J et al (2021) Complete pathological response after neoadjuvant short-course immunotherapy with ipilimumab and nivolumab in locally advanced MSI-H\/dMMR rectal cancer. Oncologist 26:e2110\u2013e2114","journal-title":"Oncologist"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-11084-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-024-11084-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-11084-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T16:05:23Z","timestamp":1736179523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-024-11084-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["11084"],"URL":"https:\/\/doi.org\/10.1007\/s00464-024-11084-3","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matthew Albert received Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from: Conmed, Ethicon, Proximie, Distal Motion, Noah, Livsmed, Applied, Medtronic, Astellas, Human Extensions, Hypervision Surgical. Mark Soliman is board member of Surgery Unified, Inc\/SurgeOn. And Advisory Board of Intuitive. Yaniv Zager, Nir Horesh, Michael Abdelmasseh, Bustamante Lopez, Leonardo Alfonso, Christopher Aquina, John RT Monson have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}